Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market
While seeing a endocrinologist the first 10 years of my diagnosis, never once was I told that changing my diet or using supplements would help
Food Science and Technology 32:661667 Committee for Medicinal Products for Human Use
Evidence classification indicated that five were Class IV (21%), and the rest were NS
Some medications and health conditions may require adjustments or extra monitoring when using GLP-1 products
Fitish RX is direct-pay telehealth with transparent, all-in pricing